Table: Human Metabolome Technologies -2021/22 group results
Aug 10 (Reuters)-
Human Metabolome Technologies, Inc.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Jun 30, 2022 Jun 30, 2021 Jun 30, 2023 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 1.22 1.12 1.30
(+8.8 pct) (+0.5 pct) (+6.3 pct)
Operating 191 mln 39 mln 240 mln
(+385.5 pct) (+25.6 pct)
Recurring 253 mln 59 mln 260 mln
(+325.3 pct) (+2.7 pct)
Net
Net 267 mln 58 mln 270 mln
(+360.0 pct) (+0.8 pct)
EPS 45.39 yen 9.87 yen 45.76 yen
EPS Diluted 45.39 yen 9.86 yen
Ann Div NIL NIL NIL
-Q2 Div NIL NIL NIL
-Q4 Div NIL NIL NIL
NOTE - Human Metabolome Technologies, Inc..
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=6090.T